Evidence map›Paper›PMID 35159802›Full record

ReviewNanomaterials (Basel, Switzerland)2022

Review on Nanoparticles and Nanostructured Materials: Bioimaging, Biosensing, Drug Delivery, Tissue Engineering, Antimicrobial, and Agro-Food Applications.

Vancha Harish, Devesh Tewari, Manish Gaur, Awadh Bihari Yadav, Shiv Swaroop, Mikhael Bechelany, Ahmed Barhoum

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Navigating theNanoscale advances · 2026
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Antibody-Empowered Nanomedicine for Precise Biomedical Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  19. Article
  20. Article

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vancha HarishSchool of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144401, India.ORCID 0000-0003-3651-0662
Devesh TewariSchool of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144401, India.ORCID 0000-0002-5125-3791
Manish GaurCentre of Biotechnology, University of Allahabad, Prayagraj, Uttar Pradesh 211002, India.
Awadh Bihari YadavCentre of Biotechnology, University of Allahabad, Prayagraj, Uttar Pradesh 211002, India.ORCID 0000-0003-2801-5071
Shiv SwaroopDepartment of Biochemistry, Central University of Rajasthan, Ajmer 305817, India.ORCID 0000-0002-7626-6513
Mikhael BechelanyInstitut Européen des Membranes, IEM UMR 5635, University Montpellier, ENSCM, CNRS, 34730 Montpellier, France.ORCID 0000-0002-2913-2846
Ahmed BarhoumNanoStruc Research Group, Chemistry Department, Faculty of Science, Ain Helwan, Cairo 11795, Egypt.ORCID 0000-0002-4859-5264

Funding

Egypt France Joint Driver (Imhotep) 43990SFIrish Research Council GOIPD/2020/340Joint Egyptian Japanese Scientific Cooperation (JEJSC) 42811
6 · The paper itself

Abstract

In the last few decades, the vast potential of nanomaterials for biomedical and healthcare applications has been extensively investigated. Several case studies demonstrated that nanomaterials can offer solutions to the current challenges of raw materials in the biomedical and healthcare fields. This review describes the different nanoparticles and nanostructured material synthesis approaches and presents some emerging biomedical, healthcare, and agro-food applications. This review focuses on various nanomaterial types (e.g., spherical, nanorods, nanotubes, nanosheets, nanofibers, core-shell, and mesoporous) that can be synthesized from different raw materials and their emerging applications in bioimaging, biosensing, drug delivery, tissue engineering, antimicrobial, and agro-foods. Depending on their morphology (e.g., size, aspect ratio, geometry, porosity), nanomaterials can be used as formulation modifiers, moisturizers, nanofillers, additives, membranes, and films. As toxicological assessment depends on sizes and morphologies, stringent regulation is needed from the testing of efficient nanomaterials dosages. The challenges and perspectives for an industrial breakthrough of nanomaterials are related to the optimization of production and processing conditions.

Indexed as

drug delivery systemsmarket and regulationsnanomaterialsnanostructuresrisks and toxicitiesskincaretissue-engineered scaffoldswound dressings

Identifiers

PMID35159802
PMCPMC8839643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.